The 14-time champion is heading for retirement at the end of the season, but no stop on his farewell tour is more significant than Roland-Garros—even if his stay only lasts one round.
Novo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts the risk of kidney failure, heart attack, stroke and death in patients with type 2 diabetes, detailed results of a long-term trial showed.
